Left atrial appendage closure after cryoballoon ablation in patients with atrial fibrillation

被引:10
|
作者
Liu, Jun [1 ]
Xia, Yu [1 ]
Zhang, Hao [1 ]
Li, Xiaofeng [1 ]
Zhang, Shu [1 ]
Fang, Pihua [1 ]
机构
[1] PUMC & CAMS, Fu Wai Hosp, Ctr Arrhythmia Diag & Treatment, Beijing, Peoples R China
关键词
Catheter ablation; Pulmonary vein isolation; Atrial flutter; Stroke; Bleeding;
D O I
10.1007/s00059-019-04880-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Cryoballoon ablation (CBA) is effective for patients with drug-refractory symptomatic atrial fibrillation (AF). For patients with a high risk of stroke (CHA(2)DS(2)-VASc score >= 2), life-long oral anticoagulation therapy should be continued even after successful catheter ablation. We investigated the safety and efficacy of concomitant use of a second-generation CBA catheter for pulmonary vein isolation (PVI) and a left atrial appendage closure (LAAC) device in patients with AF. Methods. We enrolled 27 patients (64.7 +/- 6.3 years, 74% male, 63% paroxysmal AF, 37% persistent AF, 4.8 +/- 1.4 CHA(2)DS(2)-VASc score, and 3.6 +/- 1.3 HAS-BLED score). In total, 85% of the patients had a prior stroke or TIA, and 30% of patients had a clinical history of bleeding. Patients received a CBA for PVI and underwent occlusion of the LAA with an LAAC device. The efficacy of CBA was defined as lack of arrhythmia recurrence (AF, atrial flutter, and/or atrial tachycardia lasting >= 30 s) after a 90-day blanking period. The success of LAAC was determined by the rate of stroke, TIA, and/or bleeding events. Results. The mean procedural time for CBA and LAAC was 80 +/- 16 min and 44 +/- 12 min, respectively. Acute PVI by CBA was achieved in 100% of the procedures, and 96% of patients obtained acute LAAC device placementduring the procedure. Upon complete release of the LAAC device, only 62% patients (16/26) had no detectable leakage during intraprocedural transesophageal echocardiography. Three patients experienced an acute complication: a pericardial effusion and two phrenic nerve palsy events. Mean follow-up was 18 months (range 9-23 months), and freedom from AF recurrence was 74% (20/27). Conclusion. The intraprocedural combination of CBA and LAAC is feasible in patients with non-valvular AF with a high risk of stroke, TIA, and/or bleeding. Larger long-term randomized studies are needed to judge the overall safety and efficacy of the combined procedure.
引用
收藏
页码:82 / 88
页数:7
相关论文
共 50 条
  • [31] Hospital outcomes of patients receiving catheter ablation of atrial fibrillation, left atrial appendage closure, or both
    Ramez Morcos
    Haider Al Taii
    Muni Rubens
    Anshul Saxena
    Venkataraghavan Ramamoorthy
    Mohamed Hamed
    Amr F. Barakat
    Nitin Kulkarni
    Houman Khalili
    Santiago Garcia
    Michael Megaly
    Emir Veledar
    Stavros Stavrakis
    Journal of Interventional Cardiac Electrophysiology, 2023, 66 : 913 - 921
  • [32] Combined Catheter Ablation and Left Atrial Appendage Closure in Atrial Fibrillation Patients with and without Prior Stroke
    Mo, Bin-Feng
    Zhang, Rui
    Yuan, Jia-Li
    Sun, Jian
    Zhang, Peng-Pai
    Li, Wei
    Chen, Mu
    Wang, Qun-Shan
    Li, Yi-Gang
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2021, 2021
  • [33] Effect of Left Atrial Appendage Closure in Combination With Catheter Ablation on Left Atrial Function for Persistent Atrial Fibrillation
    Yang, Jing
    Liu, Yue
    Feng, Liang
    Liu, Mingqing
    You, Ling
    Liu, Yu
    Wu, Jinglan
    Zhang, Guangming
    Geng, Xue
    Xie, Ruiqin
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [34] Left atrial appendage preservation versus closure during surgical ablation of atrial fibrillation
    Kim, Ho Jin
    Chang, Dong-Hee
    Kim, Seon-Ok
    Kim, Jin Kyoung
    Kim, Kiyun
    Jung, Sung-Ho
    Lee, Jae Won
    Kim, Joon Bum
    HEART, 2022, 108 (23) : 1864 - 1872
  • [35] Acute left atrial ridge lesion after cryoballoon ablation: How does this affect left atrial appendage closure combined procedure?
    Ren, Zhongyuan
    Jia, Peng
    Wang, Songyun
    Li, Shuang
    Li, Hailing
    Guo, Rong
    Zhang, Jingying
    Zhang, Jun
    Yang, Haotian
    Meng, Weilun
    Zheng, Yixing
    Xu, Yawei
    Zhao, Dongdong
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2020, 31 (11) : 2865 - 2873
  • [36] Editorial to "Safety and feasibility of atrial fibrillation ablation after left atrial appendage closure: A single-center experience of the left atrial appendage closure-first strategy"
    Kondo, Yusuke
    Ryuzaki, Satoko
    Kobayashi, Yoshio
    JOURNAL OF ARRHYTHMIA, 2024, 40 (04) : 891 - 892
  • [37] Cryoballoon ablation for persistent atrial fibrillation in patients without left atrial fibrosis
    Gramlich, Michael
    Maleck, Carole
    Marquardt, Jonathan
    Duckheim, Martin
    Stimpfle, Fabian
    Heinzmann, David
    Scheckenbach, Christian
    Gawaz, Meinrad
    Schreieck, Juergen
    Seizer, Peter
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2019, 30 (07) : 999 - 1004
  • [38] Percutaneous left atrial appendage closure using the LAmbre device in patients with atrial fibrillation and left atrial appendage thrombus
    Jin, Lu-Shen
    Ke, Jin-Yan
    Lin, Yuan-Nan
    Li, Ling
    Fu, Jia-Yang
    Chen, Yi-Lian
    Qiu, Yi-Xuan
    Li, Xiao-Wei
    Pan, Yang-Qi
    Li, Yue-Chun
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [39] The effect of left atrial remodeling after cryoballoon ablation and radiofrequency ablation for paroxysmal atrial fibrillation
    Wang, Xule
    Song, Beibei
    Qiu, Chunguang
    Han, Zhanying
    Wang, Xi
    Lu, Wenjie
    Chen, Xiaojie
    Chen, Yingwei
    Pan, Liang
    Sun, Guoju
    Qin, Xiaofei
    Li, Ran
    CLINICAL CARDIOLOGY, 2021, 44 (01) : 78 - 84
  • [40] Safety of Amulet Left Atrial Appendage Occluder and Watchman Device for Left Atrial Appendage Closure in Patients With Atrial Fibrillation
    Sawaya, Fadi
    Abi-Saleh, Bernard
    Hoteit, Abbas
    Jdaidany, Jennifer
    Moumneh, Mohamad B.
    Harbieh, Bernard
    Khoury, Maurice
    Aramouni, Salim
    Abdulhai, Farah
    Refaat, Marwan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)